Kyongbo Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
Full ESG analysis of Kyongbo Pharmaceutical Co Ltd are reached by signing in. This Sustainability score for Kyongbo Pharmaceutical Co Ltd represents the company's reporting of the United Nations SDGs. This dashboard contains a Q&A section about Kyongbo Pharmaceutical Co Ltd.
Kyongbo Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Kyongbo Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Kyongbo Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Kyongbo Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Kyongbo Pharmaceutical Co Ltd report the average age of the workforce?
Does Kyongbo Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Kyongbo Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Kyongbo Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Kyongbo Pharmaceutical Co Ltd offer flexible work?
Does Kyongbo Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Kyongbo Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Kyongbo Pharmaceutical Co Ltd conduct supply chain audits?
Does Kyongbo Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Kyongbo Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Kyongbo Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Kyongbo Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Kyongbo Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Kyongbo Pharmaceutical Co Ltd disclose water use targets?
Does Kyongbo Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Kyongbo Pharmaceutical Co Ltd have a product recall in the last two years?
Does Kyongbo Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Kyongbo Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Kyongbo Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Kyongbo Pharmaceutical Co Ltd disclose parental leave metrics?
Does Kyongbo Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Kyongbo Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Kyongbo Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Kyongbo Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Kyongbo Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Kyongbo Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Kyongbo Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Kyongbo Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Kyongbo Pharmaceutical Co Ltd disclose its waste policy?
Does Kyongbo Pharmaceutical Co Ltd report according to TCFD requirements?
Does Kyongbo Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Kyongbo Pharmaceutical Co Ltd disclose energy use targets?
Does Kyongbo Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Kyongbo Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Kyongbo Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients in South Korea. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also exports its products to 30 countries worldwide. The company was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd in March 2002. Kyongbo Pharmaceutical Co., Ltd was founded in 1987 and is headquartered in Asan, South Korea.